Evolution of the Average Target: Imerys

Evolution of the Target Price: Imerys

Changes in Analyst Recommendations: Imerys

69c11.RFCH1ff4cHYZYB8K_10zBUQ-wDD6vNaV59IBBTUPNI0.EAbQnLCRMzVcOG9dlAdGQi5XpXatxeTyr-ZGaXheXe9pZuLslYhEEENVKw~ea9b2a87b5debcb3caa9b9f518a89f9a
03/08 Imerys: H1 2026: The recovery is thinner than reported EBITDA suggests Alphavalue
30/04 Imerys: Q1: FX and restructuring flush earnings Alphavalue
30/04 Schneider Electric, Capgemini, Societe Generale... stocks to watch today in Paris Zonebourse
01/04 Oddo BHF maintains Outperform rating on Imerys but trims price target Zonebourse
18/03 AlphaValue/Baader Europe Slashes EPS Estimates for Imerys Amid 'More Conservative' View MT
17/03 Imerys: EPS cut (2025: from € 1.87 to -4.01, 2026: from € 2.30 to 1.22) Alphavalue
23/02 Imerys: FY 2025: Imerys turns to cost cutting as recovery remains elusive Alphavalue
23/02 Oddo BHF Maintains Outperform Rating on Imerys Zonebourse
31/25/31 Imerys: Cautious Optimism: Imerys Lays the Groundwork for Recovery Alphavalue
21/25/21 AlphaValue/Baader Europe Cuts EPS Estimates for Imerys on Weaker-than-expected H1 Results MT
20/25/20 Imerys: AlphaValue confirms buy recommendation Zonebourse
20/25/20 Imerys: Target cut by -26.3% Alphavalue
07/25/07 Imerys: H1 2025: Imerys struggles amid broad slowdown Alphavalue
30/25/30 Analysts' opinions of the day: Kering splits, news on Abivax, Soitec and Novo Nordisk Zonebourse
09/25/09 Imerys: Oddo BHF cuts target price Zonebourse
29/25/29 Imerys: Q1 '25: Decline and Uncertainty Alphavalue
21/25/21 Imerys: Margin growth despite uneven market conditions Alphavalue
21/25/21 Imerys: EPS cut (2024: -1.3%, 2025: -19.6%) Alphavalue
28/24/28 Imerys: Berenberg cuts target, maintains buy rating Zonebourse
31/24/31 Imerys: Sequential volume growth offers reassurance Alphavalue
03/24/03 Imerys: EPS cut (2024: -29.0%, 2025: -6.0%) Alphavalue
18/24/18 Imerys: up sharply after positive analysis Zonebourse
18/24/18 Imerys: a stock to own in 2025, according to Berenberg Zonebourse
11/24/11 Imerys: Target cut by -23.8% Alphavalue
01/24/01 Imerys: Gradual progress in operations amid a cautious outlook Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+12.6%
-16.83%
-2.55%
+40.1%
- - -
+36.87%
+29.24%
+45.17%
+45.86%
+23.62%
Average +23.79%
Weighted average by Cap. +5.67%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
22.78EUR
Average target price
25.65EUR
Spread / Average Target
+12.60%
High Price Target
30.00EUR
Spread / Highest target
+31.69%
Low Price Target
23.00EUR
Spread / Lowest Target
+0.97%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA